Melrose Industries PLC (MLSPF)
OTCMKTS · Delayed Price · Currency is USD
7.10
+0.01 (0.07%)
Aug 1, 2025, 3:48 PM EDT
Kronos Bio Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 3,446 | 3,468 | 3,350 | 2,954 | 6,650 | 7,132 | Upgrade | |
Revenue Growth (YoY) | -0.38% | 3.52% | 13.41% | -55.58% | -6.76% | -34.97% | Upgrade |
Cost of Revenue | 2,574 | 2,646 | 2,696 | 2,533 | 5,750 | 6,330 | Upgrade |
Gross Profit | 872 | 822 | 654 | 421 | 900 | 802 | Upgrade |
Selling, General & Admin | 377 | 830 | 598 | 690 | 1,170 | 1,225 | Upgrade |
Operating Expenses | 377 | 830 | 598 | 690 | 1,170 | 1,225 | Upgrade |
Operating Income | 495 | -8 | 56 | -269 | -270 | -423 | Upgrade |
Interest Expense | -118 | -101 | -58 | -85 | -162 | -164 | Upgrade |
Interest & Investment Income | 1 | 3 | 1 | - | 2 | 3 | Upgrade |
Earnings From Equity Investments | - | - | - | - | 38 | 32 | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | 3 | 3 | -2 | Upgrade |
Other Non Operating Income (Expenses) | - | - | -1 | -1 | -2 | -2 | Upgrade |
EBT Excluding Unusual Items | 378 | -106 | -2 | -352 | -391 | -556 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -269 | -226 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | 24 | - | - | Upgrade |
Asset Writedown | - | - | - | - | - | -184 | Upgrade |
Other Unusual Items | - | - | -6 | - | - | 287 | Upgrade |
Pretax Income | 378 | -106 | -8 | -328 | -660 | -679 | Upgrade |
Income Tax Expense | 62 | -57 | -9 | -99 | -180 | -114 | Upgrade |
Earnings From Continuing Operations | 316 | -49 | 1 | -229 | -480 | -565 | Upgrade |
Earnings From Discontinued Operations | - | - | -1,020 | -74 | 1,317 | 32 | Upgrade |
Net Income to Company | 316 | -49 | -1,019 | -303 | 837 | -533 | Upgrade |
Minority Interest in Earnings | - | - | - | -5 | -4 | -3 | Upgrade |
Net Income | 316 | -49 | -1,019 | -308 | 833 | -536 | Upgrade |
Net Income to Common | 316 | -49 | -1,019 | -308 | 833 | -536 | Upgrade |
Shares Outstanding (Basic) | 1,287 | 1,307 | 1,349 | 1,406 | 1,565 | 1,457 | Upgrade |
Shares Outstanding (Diluted) | 1,293 | 1,324 | 1,405 | 1,406 | 1,565 | 1,457 | Upgrade |
Shares Change (YoY) | -3.04% | -5.76% | -0.07% | -10.16% | 7.38% | - | Upgrade |
EPS (Basic) | 0.25 | -0.04 | -0.76 | -0.22 | 0.53 | -0.37 | Upgrade |
EPS (Diluted) | 0.25 | -0.04 | -0.76 | -0.22 | 0.53 | -0.37 | Upgrade |
Free Cash Flow | -127 | -229 | -66 | 135 | 45 | 511 | Upgrade |
Free Cash Flow Per Share | -0.10 | -0.17 | -0.05 | 0.10 | 0.03 | 0.35 | Upgrade |
Dividend Per Share | 0.064 | 0.060 | 0.050 | 0.070 | 0.052 | 0.025 | Upgrade |
Dividend Growth | 16.36% | 20.00% | -28.37% | 32.95% | 110.00% | -55.91% | Upgrade |
Gross Margin | 25.30% | 23.70% | 19.52% | 14.25% | 13.53% | 11.24% | Upgrade |
Operating Margin | 14.36% | -0.23% | 1.67% | -9.11% | -4.06% | -5.93% | Upgrade |
Profit Margin | 9.17% | -1.41% | -30.42% | -10.43% | 12.53% | -7.51% | Upgrade |
Free Cash Flow Margin | -3.69% | -6.60% | -1.97% | 4.57% | 0.68% | 7.17% | Upgrade |
EBITDA | 824 | 323 | 385 | 48 | 479 | 440 | Upgrade |
EBITDA Margin | 23.91% | 9.31% | 11.49% | 1.63% | 7.20% | 6.17% | Upgrade |
D&A For EBITDA | 329 | 331 | 329 | 317 | 749 | 863 | Upgrade |
EBIT | 495 | -8 | 56 | -269 | -270 | -423 | Upgrade |
EBIT Margin | 14.36% | -0.23% | 1.67% | -9.11% | -4.06% | -5.93% | Upgrade |
Effective Tax Rate | 16.40% | - | - | - | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.